237 related articles for article (PubMed ID: 16551864)
1. Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics.
Gilbert JA; Salavaggione OE; Ji Y; Pelleymounter LL; Eckloff BW; Wieben ED; Ames MM; Weinshilboum RM
Clin Cancer Res; 2006 Mar; 12(6):1794-803. PubMed ID: 16551864
[TBL] [Abstract][Full Text] [Related]
2. Human estrogen sulfotransferase (SULT1E1) pharmacogenomics: gene resequencing and functional genomics.
Adjei AA; Thomae BA; Prondzinski JL; Eckloff BW; Wieben ED; Weinshilboum RM
Br J Pharmacol; 2003 Aug; 139(8):1373-82. PubMed ID: 12922923
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics of gemcitabine metabolism: functional analysis of genetic variants in cytidine deaminase and deoxycytidine kinase.
Baker JA; Wickremsinhe ER; Li CH; Oluyedun OA; Dantzig AH; Hall SD; Qian YW; Ring BJ; Wrighton SA; Guo Y
Drug Metab Dispos; 2013 Mar; 41(3):541-5. PubMed ID: 23230131
[TBL] [Abstract][Full Text] [Related]
4. Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies.
Wood TC; Salavagionne OE; Mukherjee B; Wang L; Klumpp AF; Thomae BA; Eckloff BW; Schaid DJ; Wieben ED; Weinshilboum RM
J Biol Chem; 2006 Mar; 281(11):7364-73. PubMed ID: 16407288
[TBL] [Abstract][Full Text] [Related]
5. Human methylenetetrahydrofolate reductase pharmacogenomics: gene resequencing and functional genomics.
Martin YN; Salavaggione OE; Eckloff BW; Wieben ED; Schaid DJ; Weinshilboum RM
Pharmacogenet Genomics; 2006 Apr; 16(4):265-77. PubMed ID: 16538173
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism.
Sugiyama E; Kaniwa N; Kim SR; Kikura-Hanajiri R; Hasegawa R; Maekawa K; Saito Y; Ozawa S; Sawada J; Kamatani N; Furuse J; Ishii H; Yoshida T; Ueno H; Okusaka T; Saijo N
J Clin Oncol; 2007 Jan; 25(1):32-42. PubMed ID: 17194903
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomics.
Kocabas NA; Aksoy P; Pelleymounter LL; Moon I; Ryu JS; Gilbert JA; Salavaggione OE; Eckloff BW; Wieben ED; Yee V; Weinshilboum RM; Ames MM
Drug Metab Dispos; 2008 Sep; 36(9):1951-9. PubMed ID: 18556440
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Cytidine Deaminase to Thymidylate Biosynthesis in Trypanosoma brucei: Intracellular Localization and Properties of the Enzyme.
Moro-Bulnes A; Castillo-Acosta VM; Valente M; Carrero-Lérida J; Pérez-Moreno G; Ruiz-Pérez LM; González-Pacanowska D
mSphere; 2019 Aug; 4(4):. PubMed ID: 31391279
[TBL] [Abstract][Full Text] [Related]
9. Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samples.
Giovannetti E; Laan AC; Vasile E; Tibaldi C; Nannizzi S; Ricciardi S; Falcone A; Danesi R; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):720-5. PubMed ID: 18600531
[TBL] [Abstract][Full Text] [Related]
10. Human hydroxysteroid sulfotransferase SULT2B1 pharmacogenomics: gene sequence variation and functional genomics.
Ji Y; Moon I; Zlatkovic J; Salavaggione OE; Thomae BA; Eckloff BW; Wieben ED; Schaid DJ; Weinshilboum RM
J Pharmacol Exp Ther; 2007 Aug; 322(2):529-40. PubMed ID: 17496163
[TBL] [Abstract][Full Text] [Related]
11. Ethnic differences of two non-synonymous single nucleotide polymorphisms in CDA gene.
Sugiyama E; Lee SJ; Lee SS; Kim WY; Kim SR; Tohkin M; Hasegawa R; Okuda H; Kawamoto M; Kamatani N; Sawada J; Kaniwa N; Saito Y; Shin JG
Drug Metab Pharmacokinet; 2009; 24(6):553-6. PubMed ID: 20045991
[TBL] [Abstract][Full Text] [Related]
12. Determinants of the interindividual variability in serum cytidine deaminase activity of patients with solid tumours.
Cohen R; Preta LH; Joste V; Curis E; Huillard O; Jouinot A; Narjoz C; Thomas-Schoemann A; Bellesoeur A; Tiako Meyo M; Quilichini J; Desaulle D; Nicolis I; Cessot A; Vidal M; Goldwasser F; Alexandre J; Blanchet B
Br J Clin Pharmacol; 2019 Jun; 85(6):1227-1238. PubMed ID: 30701582
[TBL] [Abstract][Full Text] [Related]
13. The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>C.
Metharom E; Galettis P; Manners S; Jelinek M; Liauw W; de Souza PL; Hoskins JM; Links M
Asia Pac J Clin Oncol; 2011 Mar; 7(1):65-74. PubMed ID: 21332653
[TBL] [Abstract][Full Text] [Related]
14. High-resolution melting analysis of sequence variations in the cytidine deaminase gene (CDA) in patients with cancer treated with gemcitabine.
Raynal C; Ciccolini J; Mercier C; Boyer JC; Polge A; Lallemant B; Mouzat K; Lumbroso S; Brouillet JP; Evrard A
Ther Drug Monit; 2010 Feb; 32(1):53-60. PubMed ID: 20010457
[TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferase omega 1 and omega 2 pharmacogenomics.
Mukherjee B; Salavaggione OE; Pelleymounter LL; Moon I; Eckloff BW; Schaid DJ; Wieben ED; Weinshilboum RM
Drug Metab Dispos; 2006 Jul; 34(7):1237-46. PubMed ID: 16638819
[TBL] [Abstract][Full Text] [Related]
16. Natriuretic peptide pharmacogenetics: membrane metallo-endopeptidase (MME): common gene sequence variation, functional characterization and degradation.
Pereira NL; Aksoy P; Moon I; Peng Y; Redfield MM; Burnett JC; Wieben ED; Yee VC; Weinshilboum RM
J Mol Cell Cardiol; 2010 Nov; 49(5):864-74. PubMed ID: 20692264
[TBL] [Abstract][Full Text] [Related]
17. Cytosolic 5'-nucleotidase III (NT5C3): gene sequence variation and functional genomics.
Aksoy P; Zhu MJ; Kalari KR; Moon I; Pelleymounter LL; Eckloff BW; Wieben ED; Yee VC; Weinshilboum RM; Wang L
Pharmacogenet Genomics; 2009 Aug; 19(8):567-76. PubMed ID: 19623099
[TBL] [Abstract][Full Text] [Related]
18. Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter.
Fitzgerald SM; Goyal RK; Osborne WR; Roy JD; Wilson JW; Ferrell RE
Hum Genet; 2006 Apr; 119(3):276-83. PubMed ID: 16446974
[TBL] [Abstract][Full Text] [Related]
19. Association of xeroderma pigmentosum group D (Asp312Asn, Lys751Gln) and cytidine deaminase (Lys27Gln, Ala70Thr) polymorphisms with outcome in Chinese non-small cell lung cancer patients treated with cisplatin-gemcitabine.
Zhou M; Ding YJ; Feng Y; Zhang QR; Xiang Y; Wan HY
Genet Mol Res; 2014 Apr; 13(2):3310-8. PubMed ID: 24841663
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms.
Sugiyama E; Kaniwa N; Kim SR; Hasegawa R; Saito Y; Ueno H; Okusaka T; Ikeda M; Morizane C; Kondo S; Yamamoto N; Tamura T; Furuse J; Ishii H; Yoshida T; Saijo N; Sawada J
Clin Pharmacokinet; 2010 Aug; 49(8):549-58. PubMed ID: 20608756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
